EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Selection for transcatheter versus surgical aortic valve replacement and mid-term survival: results of the AUTHEARTVISIT study

Johann Auer, Pavla Krotka, Berthold Reichardt, Denise Traxler iD, Ralph Wendt, Michael Mildner, Hendrik Jan Ankersmit, Alexandra Graf

European Journal of Cardio-Thoracic Surgery · 01.07.2024 · 66 (1)

DOI: 10.1093/ejcts/ezae214 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift European Journal of Cardio-Thoracic Surgery, online erschienen am 14.06.2024. Verfasst von Johann Auer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I with Cardiology and Intensive Care, St Josef Hospital Braunau, Braunau am Inn, Austria. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis, Heart Valve Prosthesis Implantation, Aortic Valve. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES Limited data are available from randomized trials comparing outcomes between transcatheter aortic valve replacement (TAVR) and surgery in patients with different risks and with follow-up of at least 4 years or longer. In this large, population-based cohort study, long-term mortality and morbidity were investigated in patients undergoing aortic valve replacement (AVR) for severe aortic stenosis using a surgically implanted bioprosthesis (surgical/biological aortic valve replacement; sB-AVR) or TAVR. METHODS Individual data from the Austrian Insurance Funds from 2010 through 2020 were analysed. The primary outcome was all-cause mortality, assessed in the overall and propensity score-matched populations. Secondary outcomes included reoperation and cardiovascular events. RESULTS From January 2010 through December 2020, a total of 18 882 patients underwent sB-AVR (n = 11 749; 62.2%) or TAVR (n = 7133; 37.8%); median follow-up was 5.8 (95% CI 5.7–5.9) years (maximum 12.3 years). The risk of all-cause mortality was higher with TAVR compared with sB-AVR: hazard ratio 1.552, 95% confidence interval (CI) 1.469–1.640, P < 0.001; propensity score-matched hazard ratio 1.510, 1.403–1.625, P < 0.001. Estimated median survival was 8.8 years (95% CI 8.6–9.1) with sB-AVR versus 5 years (4.9–5.2) with TAVR. Estimated 5-year survival probability was 0.664 (0.664–0.686) with sB-AVR versus 0.409 (0.378–0.444) with TAVR overall, and 0.690 (0.674–0.707) and 0.560 (0.540–0.582), respectively, with propensity score matching. Separate subgroup analyses for patients aged 65–75 years and >75 years indicated a significant survival benefit in patients selected for sB-AVR in both groups. Other predictors of mortality were age, sex, previous heart failure, diabetes and chronic kidney disease. CONCLUSIONS In this retrospective national population-based study, selection for TAVR was significantly associated with higher all-cause mortality compared with sB-AVR in patients ≥65 years with severe, symptomatic aortic stenosis in the >2-year follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementAortic Valve StenosisHeart Valve Prosthesis ImplantationAortic ValveHumansFemaleMaleAgedAged, 80 and overPatient SelectionRetrospective StudiesPropensity ScoreHeart Valve ProsthesisTreatment OutcomeBioprosthesisRisk FactorsFollow-Up Studies

Stichwörter der Autor:innen

AUTHEARTVISITBioprosthesisTranscatheter aortic valve replacement

Autor:innen und Institutionen

  • Department of Internal Medicine I with Cardiology and Intensive Care, St Josef Hospital Braunau, Braunau am Inn, Austria.
  • Center for Medical Data Science, Medical University of Vienna, Vienna, Austria.
  • Austrian Social Health Insurance Fund, Eisenstadt, Austria.
  • Clinic of Thoracic Surgery, Medical University of Vienna, Vienna, Austria.
  • Laboratory for Cardiac and Thoracic Diagnosis, Regeneration and Applied Immunology, Vienna, Austria.
  • Department of Oral and Maxillofacial Surgery, Medical University of Vienna, Vienna, Austria.

ORCID-Profile: Denise Traxler

Zitieren

APA

Auer, J., Krotka, P., Reichardt, B., Traxler, D., Wendt, R., Mildner, M., Ankersmit, H. J., & Graf, A. (2024). Selection for transcatheter versus surgical aortic valve replacement and mid-term survival: results of the AUTHEARTVISIT study. European Journal of Cardio-Thoracic Surgery, 66(1). https://doi.org/10.1093/ejcts/ezae214

Vancouver

Auer J, Krotka P, Reichardt B, Traxler D, Wendt R, Mildner M, et al. Selection for transcatheter versus surgical aortic valve replacement and mid-term survival: results of the AUTHEARTVISIT study. European Journal of Cardio-Thoracic Surgery. 2024;66(1). doi:10.1093/ejcts/ezae214

BibTeX
@article{Auer2024,
  author = {Auer, Johann and Krotka, Pavla and Reichardt, Berthold and Traxler, Denise and Wendt, Ralph and Mildner, Michael and Ankersmit, Hendrik Jan and Graf, Alexandra},
  title = {Selection for transcatheter versus surgical aortic valve replacement and mid-term survival: results of the AUTHEARTVISIT study},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2024},
  volume = {66},
  number = {1},
  doi = {10.1093/ejcts/ezae214}
}
Kostenlos starten →